Novartis Group Russia

Novartis is an international pharmaceutical company headquartered in Basel, Switzerland. Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 104 thousand people of more than 149 nationalities work at Novartis around the world. Novartis Group in Russia offers healthcare solutions that meet the most urgent needs of society and patients. The company develops research and educational activities in partnership with the leading universities and research institutes, implements various programs to improve the healthcare system, and conducts international and local clinical trials. Novartis has a diversified product portfolio and occupies leading positions in the Russian market in the production of innovative and replicated drugs. All Group’s divisions are currently presented in Russia - innovative products, generic pharmaceutical and biosimilars, own manufacturing site production in St. Petersburg - while the number of employees approaches 2,000.

Back to the list